Breaking News, Financial News

Financial Report: Wockhardt

Earnings drop 70% as three India plants face export restrictions

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Wockhardt   2Q Revenues: 12.0 billion rupees (-11%) 2Q Earnings: 1.4 billion rupees (-70%) YTD Revenues: 26.0 billion rupees (-5%) YTD Earnings: 4.6 billion rupees (-44%) Comments: Results were impacted by restrictions on shipping medicines to the U.S. and UK from one of its factories after health regulators identified deficiencies at the plant. The UK’s MHRA recently added restrictions on exports from two other factories. According to a Wockhardt statement, the U.S. import alert, reported i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters